Generalized Anxiety Clinical Trial
Official title:
Meditation and Yoga for Heightened Anxiety Related to COVID-19
Verified date | May 2021 |
Source | Research Foundation for Mental Hygiene, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This randomized clinical on-line study examines whether whether a daily practice of meditation or Kundalini Yoga with anxiety reduction training leads to a greater reduction in anxiety than anxiety reduction training alone.
Status | Active, not recruiting |
Enrollment | 360 |
Est. completion date | January 30, 2022 |
Est. primary completion date | April 19, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: 1. Heightened anxiety triggered or exacerbated by COVID-19 2. Anxiety it least mild-moderate in severity 3. English speaking and living in the United States 4. Access to a smart phone, tablet, or computer with internet 5. Able to read and understand English Exclusion Criteria: 1. Individuals with severe depression or substance abuse 2. Individuals with a current or past history of psychosis, bipolar disorder, or PTSD. 3. Individuals with physical disability that might make study participation difficult. 4. Individuals with an unstable medical illness or a history of cardiac disease 5. Individuals with a current daily practice of meditation or Kundalini yoga 6. Individuals with confirmed or suspected COVID-19 7. Individuals who are currently pregnant or anticipate being pregnant during study |
Country | Name | City | State |
---|---|---|---|
United States | Columbia University Department of Psychiatry | New York | New York |
United States | ProofPilot (Virtual Study: https://proofpilot.com/covid-anxiety/) | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Research Foundation for Mental Hygiene, Inc. |
United States,
Andersson E, Enander J, Andrén P, Hedman E, Ljótsson B, Hursti T, Bergström J, Kaldo V, Lindefors N, Andersson G, Rück C. Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychol Med. 2012 Oct;42(10):2193-203. doi: 10.1017/S0033291712000244. Epub 2012 Feb 21. — View Citation
Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005;12(4):278-85. — View Citation
Grossman P, Kappos L, Gensicke H, D'Souza M, Mohr DC, Penner IK, Steiner C. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology. 2010 Sep 28;75(13):1141-9. doi: 10.1212/WNL.0b013e3181f4d80d. — View Citation
Khalsa MK, Greiner-Ferris JM, Hofmann SG, Khalsa SB. Yoga-enhanced cognitive behavioural therapy (Y-CBT) for anxiety management: a pilot study. Clin Psychol Psychother. 2015 Jul-Aug;22(4):364-71. doi: 10.1002/cpp.1902. Epub 2014 May 7. — View Citation
Kladnitski N, Smith J, Uppal S, James MA, Allen AR, Andrews G, Newby JM. Transdiagnostic internet-delivered CBT and mindfulness-based treatment for depression and anxiety: A randomised controlled trial. Internet Interv. 2020 Feb 13;20:100310. doi: 10.1016/j.invent.2020.100310. eCollection 2020 Apr. — View Citation
Shannahoff-Khalsa D, Fernandes RY, Pereira CAB, March JS, Leckman JF, Golshan S, Vieira MSR, Polanczyk GV, Miguel EC, Shavitt RG. Kundalini Yoga Meditation Versus the Relaxation Response Meditation for Treating Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial. Front Psychiatry. 2019 Nov 11;10:793. doi: 10.3389/fpsyt.2019.00793. eCollection 2019. — View Citation
Spijkerman MP, Pots WT, Bohlmeijer ET. Effectiveness of online mindfulness-based interventions in improving mental health: A review and meta-analysis of randomised controlled trials. Clin Psychol Rev. 2016 Apr;45:102-14. doi: 10.1016/j.cpr.2016.03.009. Epub 2016 Apr 1. Review. — View Citation
Wang YY, Li XH, Zheng W, Xu ZY, Ng CH, Ungvari GS, Yuan Z, Xiang YT. Mindfulness-based interventions for major depressive disorder: A comprehensive meta-analysis of randomized controlled trials. J Affect Disord. 2018 Mar 15;229:429-436. doi: 10.1016/j.jad.2017.12.093. Epub 2018 Jan 3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | GAD-7 | Generalized Anxiety Disorder 7-item scale (range 0-21, higher is worse) | Up to 32 weeks | |
Primary | Whiteley 8 | Health Anxiety 8-item scale (range 0-32, higher is worse) | Up to 32 weeks | |
Secondary | PHQ-8 | Patient Health Questionnaire 8 - an 8 item measure of depression (range 0-24, higher is worse) | Up to 32 weeks | |
Secondary | SS-8 | Somatic Symptom Scale-8 an 8-item measure of symptom burden (range 0-32, higher is worse) | Up to 32 weeks | |
Secondary | Applied Cognition 1.0 | An 8-item self-report measure of cognitive function (range 8-40, higher is worse) | Up to 32 weeks | |
Secondary | PROMIS-4 Sleep Disturbance | A 4-item self-report assessment of sleep disturbance (range 4-20, higher is worse) | Up to 32 weeks | |
Secondary | ERQ | Emotional Regulation Questionnaire - a 10-item measure of emotional regulation; the reappraisal subscale has a range: of 6-42, higher score is considered positive; while the suppression subscale has a range of 4-28, higher score considered negative. .. | Up to 32 weeks | |
Secondary | Perceived Stress Scale | A 10-item scale assessing the perception of events in one's life as stressful (0-40, higher represents higher perception of stress) | Up to 32 weeks | |
Secondary | Brief Hypervigilance Scale | A 5-item scale assessing hypervigilance (0-20, higher represents greater hypervigilance) | Up to 32 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00390533 -
An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder
|
Phase 3 | |
Not yet recruiting |
NCT06081348 -
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
|
Phase 2 | |
Recruiting |
NCT04702711 -
Experiences of Anger in Patients in Primary Health Care With Symptoms of Generalized Anxiety
|
||
Active, not recruiting |
NCT04751864 -
Brain Stimulation & Generalized Anxiety Study
|
Phase 4 | |
Completed |
NCT02678624 -
Project Collabri for Treatment of Anxiety
|
N/A | |
Completed |
NCT04356365 -
The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's)
|
||
Not yet recruiting |
NCT04442360 -
The Impact of Information Sources on Mental Health During the COVID-19 Pandemic
|
||
Not yet recruiting |
NCT04183946 -
Willkommen Mutterglück: Online CBT for Pregnant and Postpartum Women With Depression and Anxiety
|
N/A | |
Not yet recruiting |
NCT03445143 -
GATE: Generalized Anxiety - A Treatment Evaluation
|
N/A | |
Completed |
NCT03205332 -
Training Mental Habits Study
|
N/A | |
Not yet recruiting |
NCT04378257 -
Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic
|
Phase 3 | |
Recruiting |
NCT03528109 -
Improving Access to Child Anxiety Treatment
|
N/A | |
Not yet recruiting |
NCT03015285 -
CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT
|
N/A | |
Completed |
NCT04510519 -
Scaling Mental Healthcare in COVID-19 With Voice Biomarkers
|
||
Completed |
NCT00417118 -
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder
|
Phase 3 | |
Recruiting |
NCT06146530 -
Cerina-A Pilot Randomized Controlled Trial
|
N/A | |
Completed |
NCT02872051 -
Integrated Mental Health Care and Vocational Rehabilitation to Individuals on Sick Leave Due to Anxiety and Depression
|
N/A | |
Completed |
NCT02148042 -
Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa
|
||
Recruiting |
NCT05292807 -
Imagery Rescripting and Imaginal Exposure for Anxiety Symptoms
|
N/A |